Back
Ocular Therapeutix Stock Price Chart

Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
34
OCUL
Ocular Therapeutix
Last Price:
$7.67
Seasonality Move:
-7.66%
7 Day Trial
ALL ACCESS PASS
$
7

Meet the Founder That's Revolutionizing Smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is relatively stagnant and OCUL is experiencing slight selling pressure.
Ocular Therapeutix Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.61 | Sell |
20-day SMA: | 7.4 | Buy |
50-day SMA: | 7.62 | Sell |
200-day SMA: | 8.33 | Sell |
8-day EMA: | 7.59 | Sell |
20-day EMA: | 7.54 | Sell |
50-day EMA: | 7.75 | Sell |
200-day EMA: | 7.99 | Sell |
Ocular Therapeutix Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.02 | Buy |
Relative Strength Index (14 RSI): | 49.64 | Sell |
Chaikin Money Flow: | -194129 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.82 - 7.9) | Buy |
Bollinger Bands (100): | (7.36 - 9.78) | Sell |
Ocular Therapeutix Technical Analysis
Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Ocular Therapeutix Stock
Is Ocular Therapeutix Stock a Buy?
-
Ocular Therapeutix share price is 7.53 while OCUL 8-day simple moving average is 7.61, which is a Sell signal.
-
The stock price of OCUL is 7.53 while Ocular Therapeutix 20-day SMA is 7.40, which makes it a Buy.
-
Ocular Therapeutix 50-day simple moving average is 7.62 while OCUL share price is 7.53, making it a Sell technically.
-
OCUL stock price is 7.53 and Ocular Therapeutix 200-day simple moving average is 8.33, creating a Sell signal.
OCUL Technical Analysis vs Fundamental Analysis
Sell
34
Ocular Therapeutix (OCUL)
is a Sell
Is Ocular Therapeutix a Buy or a Sell?
-
Ocular Therapeutix stock is rated a SellThe current Ocular Therapeutix [OCUL] share price is $7.53. The Score for OCUL is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
Ocular Therapeutix Stock Info
Market Cap:
1.2B
Price in USD:
7.53
Share Volume:
1.2M
Ocular Therapeutix 52-Week Range
52-Week High:
11.78
52-Week Low:
4.06
Sell
34
Ocular Therapeutix (OCUL)
is a Sell
Ocular Therapeutix Share Price Forecast
-
What is the Ocular Therapeutix stock price today?The Ocular Therapeutix stock price is 7.53 USD today.
-
Will OCUL stock go up or go down?Ocular Therapeutix> share price is forecast to RISE/FALL based on technical indicators
-
Is Ocular Therapeutix overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Ocular Therapeutix is overvalued.
Is Ocular Therapeutix Stock a Buy?
-
Ocular Therapeutix share price is 7.53 while OCUL 8-day exponential moving average is 7.59, which is a Sell signal.
-
The stock price of OCUL is 7.53 while Ocular Therapeutix 20-day EMA is 7.54, which makes it a Sell.
-
Ocular Therapeutix 50-day exponential moving average is 7.75 while OCUL share price is 7.53, making it a Sell technically.
-
OCUL stock price is 7.53 and Ocular Therapeutix 200-day simple moving average is 7.99, creating a Sell signal.
Fundamental Analysis of Ocular Therapeutix
Is Ocular Therapeutix a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.09 per share, an increase next quarter of $0.01 per share, a decrease this year of $0.14 per share, and an increase next year of $0.03 per share.
Technical Analysis of Ocular Therapeutix
Should I short Ocular Therapeutix stock?
-
OCUL Moving Average Covergence Divergence (MACD) indicator is 0.02, suggesting Ocular Therapeutix is a Buy
-
Ocular Therapeutix Relative Strength Index (RSI) is 49.64, which suggest Ocular Therapeutix is oversold
-
The Bollinger Bands (25) for Ocular Therapeutix is (6.82 - 7.9), which suggest Ocular Therapeutix is a Sell
-
The Bollinger Bands (100) for Ocular Therapeutix is (7.36 - 9.78), which suggest Ocular Therapeutix is a Sell
* Ocular Therapeutix stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.